APA-viite

Joy, M. S., Gipson, D. S., Powell, L., MacHardy, J., Jennette, J. C., Vento, S., . . . Trachtman, H. (2009). Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group.

Chicago-tyylinen lähdeviittaus

Joy, Melanie S., et al. Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group. 2009.

MLA-viite

Joy, Melanie S., et al. Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group. 2009.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.